Atrial Fibrillation Devices Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Biosensense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation

The global Atrial Fibrillation Devices market size was valued at US$ 3.5 Billion in 2021 and is expected to reach US$ 15.9 Billion by 2027, growing at a CAGR of 17.9% over the forecast period.

Atrial Fibrillation Devices Market Overview

Atrial fibrillation is a condition that causes the heart to beat irregularly rather than normally. The heart's atria, or top chambers, quickly beat, which causes blood flow to halt or stop altogether. Additionally, the ventricles have erratic heartbeats and inadequate blood circulation. Due to reasons including an ageing population and a rise in medical tourism, the business is expected to grow. The atrial fibrillation sector is growing as a result of obesity, hypertension, metabolic syndrome, and diabetes. Atrial fibrillation (AF), the most common kind of arrhythmia, causes an unsteady and frequently rapid heartbeat. There has been evidence of an increase in the prevalence of atrial fibrillation worldwide. Atrial fibrillation sufferers are becoming more prevalent, which is a major concern.

Atrial fibrillation devices market expansion will primarily be fueled by rising acceptance rates of cutting-edge technology and the presence of sophisticated healthcare infrastructure. Additionally, the region of North America's growing senior population will support market expansion. In developed nations, the availability of advantageous reimbursement scenarios should also prove to be a high effect rendering element. Increased sedentary lifestyles and binge eating behaviors in developing regions will increase the prevalence of cardiovascular diseases, which will increase acceptance rates in both developed and in some developing regions.

Industry News and Updates:

07 Oct 2020: FDA approves Biosense Webster’s ablation catheter to treat persistent atrial fibrillation --

Biosense Webster, part of the Johnson & Johnson Family of Companies, has secured approval from the US Food and Drug Administration (USFDA) for its Thermocool Smarttouch SF ablation catheter to treat persistent atrial fibrillation (persistent AF). The device’s approval was based on data from the prospective and multi-centre PRECEPT study, which achieved safety and effectiveness endpoints.

What are the major Applications, Types and Regions for Atrial Fibrillation Devices Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Catheter Ablation


• Maze Surgery

By Application, it is segmented into

• Hospitals


• Clinics


• Ambulatory Surgical Centers


• Others

Atrial Fibrillation Devices Market Regional Analysis

The market for atrial fibrillation devices in Germany is predicted to rise as the use of less invasive catheter ablation techniques grows. The country's easy reimbursement system should also increase demand for cutting-edge atrial fibrillation devices. The U.S. market size was over USD 2.25 billion in 2018, driven by the nation's role as the leading adopter of new technologies and its status as the region with the most advanced facilities for atrial fibrillation operations. It will have minimal growth because there aren't many needs that can be met. The market for atrial fibrillation devices in China is anticipated to develop at a CAGR of more than 17.6% by 2025, driven by increased heart disease prevalence as a result of abrupt changes in lifestyle-related habits and rising trends in cigarette use among millennials. The development of hospitals, the creation of new healthcare facilities, and the rising popularity of private clinics have all boosted industry earnings. The growing number of baby boomers who are susceptible to heart disorders and the current unmet need are the main drivers of market growth throughout the forecast period.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Atrial Fibrillation Devices Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Atrial Fibrillation Devices Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Atrial Fibrillation Devices Market report scope?

Key Takeaways from this Atrial Fibrillation Devices Market Report

• Evaluate Atrial Fibrillation Devices market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Atrial Fibrillation Devices market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Atrial Fibrillation Devices Market?

The Atrial Fibrillation Devices Market is growing at a CAGR of 17.9% over the next 5 years.

Who are the key players in Atrial Fibrillation Devices Market?

Biosensense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, AtriCure, Inc., Japan Lifeline Co., Biotronik, Inc, MicroPort Scientific Corporation, Biomerics, CathRx, Philips, Synaptic Medical, Osypka AG, CardioFocus, Lepu Medical, APT Med, TZ Medical

What are the significant types of Atrial Fibrillation Devices Market?

Catheter Ablation, Maze Surgery

What are the major end-use applications of Atrial Fibrillation Devices Market?

Hospitals, Clinics, Ambulatory Surgical Centers, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.